TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Roche Diagnostics Norge AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
2,384,285
|
1,407,387
|
613,896 |
Financial expenses |
1,390
|
719
|
1,026 |
Earnings before taxes |
111,140
|
21,834
|
23,890 |
Total assets |
383,419
|
670,162
|
327,488 |
Current assets |
333,623
|
655,363
|
309,310 |
Current liabilities |
283,800
|
554,573
|
235,316 |
Equity capital |
99,618
|
115,589
|
92,172 |
- share capital |
6,174
|
5,988
|
5,575 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
26.0%
|
17.2%
|
28.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
4.7%
|
1.6%
|
3.9% |
Return on assets (ROA) |
29.3%
|
3.4%
|
7.6% |
Current ratio |
117.6%
|
118.2%
|
131.4% |
Return on equity (ROE) |
111.6%
|
18.9%
|
25.9% |
Change turnover |
933,289
|
747,929
|
100,898 |
Change turnover % |
64%
|
113%
|
20% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.